Wintex 1 Injection contains Ceftriaxone 1000 mg, a third-generation cephalosporin antibiotic with broad-spectrum bactericidal activity. It is indicated for the treatment of various bacterial infections including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and meningitis caused by susceptible organisms. Ceftriaxone exerts its effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The drug demonstrates excellent penetration into most body tissues and fluids, including cerebrospinal fluid, making it effective against central nervous system infections. Wintex 1 Injection is administered via intramuscular or intravenous routes, with dosing adjusted according to the severity and type of infection, as well as patient-specific factors such as renal function. It is generally well tolerated, although potential adverse effects may include hypersensitivity reactions, gastrointestinal disturbances, and local injection site reactions. Caution is advised in patients with a history of penicillin allergy due to possible cross-reactivity. Wintex 1 Injection should be used under strict medical supervision, with appropriate microbiological testing to ensure susceptibility and to minimize the development of antibiotic resistance.